8-year-old Indian dies after falling out of car in UAE

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Dubai, Feb 11: An Indian national has been diagnosed with the novel coronavirus in the UAE, bringing the total number of confirmed infection cases to eight, the country's health ministry has said.

The death toll in China's coronavirus outbreak has gone up to 1,016 while the confirmed cases of infection have soared to 42,638, Chinese health officials said on Tuesday.

The UAE Ministry of Health and Prevention (MoHAP) said on Monday that the Indian national was infected after he interacted with a recently diagnosed person.

"The Ministry of Health and Prevention announced today the eighth confirmed case of new coronavirus in the UAE, which is an Indian national who had interacted with a recently diagnosed person," it said in a tweet.

On Sunday, the ministry said that the two new patients, a Chinese national and a Filipino, had been diagnosed with the disease and were receiving medical care as per the highest health standards available in the country.

It said that all health facilities will continue to report any new cases suspected to have coronavirus.

Last week, a family of four who arrived from Wuhan for a holiday in Dubai were diagnosed with coronavirus. A fifth patient, who also arrived from the Chinese city, was confirmed to have been infected with 
the virus, but is reportedly in a stable condition.

China and countries around the world are scrambling to contain the spread of coronavirus which fiirst surfaced in Wuhan city in the Central Hubei province of China. Apart from China, two deaths have occurred in Hong Kong and the Philippines.

Besides Germany, Britain and Italy, other European nations with cases of the virus include France, Russia, Belgium, Sweden, Finland and Spain.

New Delhi, May 29: The Reserve Bank of India (RBI) has imposed a monetary penalty of Rs 1.2 crore on Karnataka Bank Limited for non-compliance of asset classification, divergence and provisioning norms.

"The penalty has been imposed in exercise of powers vested in RBI under the provisions of Section 47 A (1) (c) read with Section 46 (4) (i) of the Banking Regulation Act, 1949. 

This action is based on the deficiencies in regulatory compliance and is not intended to pronounce upon the validity of any transaction or agreement entered into by the bank with its customers," the central bank said in a statement on Thursday.

According to the central bank, the statutory inspection of the bank with reference to its financial position as on March 31, 2017, and as on March 31, 2018, and the Risk Assessment Reports (RAR) pertaining thereto revealed, inter-alia, non-compliance with the directions issued by RBI.

Earlier, a notice was issued to the bank advising it to show cause as to why penalty should not be imposed on it for non-compliance with the directions.

After considering the bank's reply to the notice, oral submissions made in the personal hearing and examination of additional submissions, RBI concluded that the charges of non-compliance with RBI directions warranted imposition of monetary penalty, according to a release.

This action is based on the deficiencies in regulatory compliance and is not intended to pronounce upon the validity of any transaction or agreement entered into by the bank with its customers.